Literature DB >> 20055697

Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment.

Jibran Y Khokhar1, Charmaine S Ferguson, Andy Z X Zhu, Rachel F Tyndale.   

Abstract

Drug dependency is a highly prevalent mental health disorder that imposes a significant burden on those directly affected, health care systems, and society in general. There is substantial heritability in the susceptibility to drug addiction, which indicates that there are genetic risk factors. Variation in the human genome is abundant and can directly affect drug dependency phenotypes, for example, by altering the function of a gene product or by altering gene expression. Pharmacogenetic studies can assess the effects of genetic variation on the risk for a particular phenotype (e.g., being an alcoholic). In addition, pharmacogenetic variability in treatment efficacy and adverse reactions can be investigated to identify particular genetic variants associated with altered responses. This review highlights examples of genetic variations that are important in the development and maintenance of specific drug dependencies as well as those that affect the response to treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20055697     DOI: 10.1146/annurev.pharmtox.010909.105826

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  10 in total

1.  Enhancing the effectiveness of smoking cessation interventions: a cancer prevention imperative.

Authors:  Anthony J Alberg; Matthew J Carpenter
Journal:  J Natl Cancer Inst       Date:  2012-01-25       Impact factor: 13.506

2.  Acute ethanol does not always affect delay discounting in rats selected to prefer or avoid ethanol.

Authors:  Clare J Wilhelm; Suzanne H Mitchell
Journal:  Alcohol Alcohol       Date:  2012-05-29       Impact factor: 2.826

Review 3.  Addiction and brain reward and antireward pathways.

Authors:  Eliot L Gardner
Journal:  Adv Psychosom Med       Date:  2011-04-19

Review 4.  Cytochrome P450-mediated drug metabolism in the brain.

Authors:  Sharon Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

Review 5.  The genetic basis of delay discounting and its genetic relationship to alcohol dependence.

Authors:  Suzanne H Mitchell
Journal:  Behav Processes       Date:  2011-02-24       Impact factor: 1.777

Review 6.  Breaking barriers in the genomics and pharmacogenetics of drug addiction.

Authors:  M K Ho; D Goldman; A Heinz; J Kaprio; M J Kreek; M D Li; M R Munafò; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2010-10-27       Impact factor: 6.875

7.  Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study.

Authors:  Eric A Woodcock; Leslie H Lundahl; Margit Burmeister; Mark K Greenwald
Journal:  Am J Addict       Date:  2015-04-24

8.  BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study.

Authors:  Mark K Greenwald; Caren L Steinmiller; Elzbieta Sliwerska; Leslie Lundahl; Margit Burmeister
Journal:  Addict Biol       Date:  2012-02-16       Impact factor: 4.280

9.  Coupled positive and negative feedbacks produce diverse gene expression patterns in colonies.

Authors:  Namiko Mitarai; Mogens Høgh Jensen; Szabolcs Semsey
Journal:  MBio       Date:  2015-04-07       Impact factor: 7.867

Review 10.  Drug Interactions With New Synthetic Opioids.

Authors:  Clara Pérez-Mañá; Esther Papaseit; Francina Fonseca; Adriana Farré; Marta Torrens; Magi Farré
Journal:  Front Pharmacol       Date:  2018-10-11       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.